241 related articles for article (PubMed ID: 188769)
21. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
[TBL] [Abstract][Full Text] [Related]
22. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
Joncas JH; Rioux E; Wastiaux JP; Leyritz M; Robillard L; Menezes J
Can Med Assoc J; 1976 Nov; 115(9):858-60. PubMed ID: 186168
[TBL] [Abstract][Full Text] [Related]
23. Acute lymphoblastic leukemia of Burkitt's type (L3 ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulins.
Gluck WL; Bigner SH; Borowitz MJ; Brenckman WD
Am J Clin Pathol; 1986 May; 85(5):636-40. PubMed ID: 3486584
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic studies on human lymphoblastoid cell lines from Burkitt's lymphomas and other sources.
Jarvis JE; Ball G; Rickison AB; Epstein MA
Int J Cancer; 1974 Dec; 14(6):716-21. PubMed ID: 4377002
[TBL] [Abstract][Full Text] [Related]
25. Chromosome #14 markers in two Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines of normal origin differ from the Burkitt lymphoma (BL)-associated 14q+ marker.
Manolov G; Manolova Y; Klein G; Levan A; Kieler J
Cancer Genet Cytogenet; 1981 Oct; 4(2):179-84. PubMed ID: 6277469
[TBL] [Abstract][Full Text] [Related]
26. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
[TBL] [Abstract][Full Text] [Related]
27. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.
Clements GB; Klein G; Povey S
Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210
[TBL] [Abstract][Full Text] [Related]
28. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
29. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Steel CM; Morten JE; Foster E
IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
[TBL] [Abstract][Full Text] [Related]
30. Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines.
Yefenof E; Klein G
Int J Cancer; 1977 Sep; 20(3):347-52. PubMed ID: 198382
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells.
Harris RS; Croom-Carter DS; Rickinson AB; Neuberger MS
J Virol; 2001 Nov; 75(21):10488-92. PubMed ID: 11581418
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a newly established human Burkitt's lymphoma cell line, OMA-BL-1.
Joshi SS; DeBoer JM; Strandjord SJ; Pirruccello SJ; Sanger WG; Weisenburger DD; Sharp JG
Int J Cancer; 1991 Mar; 47(5):643-8. PubMed ID: 1848532
[TBL] [Abstract][Full Text] [Related]
33. Establishment of an Epstein-Barr virus-negative B-cell lymphoma line from a Japanese Burkitt's lymphoma and its serial passage in hamsters.
Miyoshi I; Hiraki S; Kubonishi I; Matsuda Y; Kishimoto H; Nakayama T; Tanaka T; Masuji H; Kimura I
Cancer; 1977 Dec; 40(6):2999-3003. PubMed ID: 201360
[TBL] [Abstract][Full Text] [Related]
34. Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line.
Finerty S; Rowe M; Berry PJ; Ranson DL; Mott MG; Gregory CD; Rickinson AB
Br J Cancer; 1986 Sep; 54(3):385-91. PubMed ID: 3019376
[TBL] [Abstract][Full Text] [Related]
35. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma.
Lenoir GM; Preud'homme JL; Bernheim A; Berger R
Nature; 1982 Jul; 298(5873):474-6. PubMed ID: 6806672
[TBL] [Abstract][Full Text] [Related]
36. [Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma?].
Berger R; Bernheim A
C R Acad Sci III; 1984; 298(6):143-5. PubMed ID: 6324967
[TBL] [Abstract][Full Text] [Related]
37. A novel Japanese Burkitt's lymphoma cell line, P32/Ishida, with a new variant chromosomal translocation (2;14).
Hirose M; Minato K; Tobinai K; Ise T; Watanabe S; Shimoyama M; Abe T
Gan; 1983 Dec; 74(6):878-86. PubMed ID: 6667834
[TBL] [Abstract][Full Text] [Related]
38. [Burkitt's lymphoma in 1985].
Philip T; Lenoir GM; Favrot M; Philip I; Brunat-Mentigny M
Pediatrie; 1985 Mar; 40(2):137-60. PubMed ID: 3001632
[TBL] [Abstract][Full Text] [Related]
39. Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice.
Povlsen CO; Fialkow PJ; Klein E; Klein G; Rygaard J; Wiener F
Int J Cancer; 1973 Jan; 11(1):30-9. PubMed ID: 4364324
[No Abstract] [Full Text] [Related]
40. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
